Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
68 pending office actions • 39 clients • 65 examiners • 39 art units • 0 of 68 (0%) have an AI response strategy ready
Raphael Bellum PLLC operates in the Biotechnology & Pharmaceuticals technology area with 2043 career applications. The firm has a resolved allowance rate of 80.06 percent. An average of 3.61 office actions per allowance is required to reach resolution. Currently, the firm is handling 50 pending office actions.
The 3.61 average reflects the prosecution cycle for the 2043 applications in the biotech and pharma sectors. This data point assists in managing expectations for the 50 pending actions currently on the firm's docket.
Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 13 (19%) |
| §103 only | 12 (18%) |
| §102 only | 3 (4%) |
| §112 only | 9 (13%) |
| Double-patenting only | 1 (1%) |
| Double-patenting + other | 5 (7%) |
| Multi-statute (no §101) | 24 (35%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, ERIC | 2 | 70.8% | +23.3% |
| JONES, CHRISTOPHER P | 2 | 76.1% | +24.8% |
| VIVLEMORE, TRACY ANN | 2 | 73.0% | +6.6% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.3% | +38.2% |
| MORAN, KATHERINE M | 1 | 54.2% | +24.2% |
| QUAIM, LAMIA | 1 | 74.0% | +17.8% |
| WALKER, CHRISTOPHER RICHARD | 1 | 72.9% | +18.3% |
| GOODMAN, MATTHEW PARKER | 1 | 20.2% | +30.3% |
| ANDERSON, JAMES D | 1 | 55.1% | +19.3% |
| OH, TAYLOR V | 1 | 81.2% | +15.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18898755 | CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS | OH, TAYLOR V | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | SPAINE, ROBERT FRANKLIN | 441d overdue |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | MYERS, CARLA J | 187d overdue |
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | AWORUNSE, OLUWABUSAYO ADEBANJO | 146d overdue |
| 16456773 | RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY | VIVLEMORE, TRACY ANN | 98d overdue |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 44d overdue |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | ANDERSON, JAMES D | 44d overdue |
| 17747557 | MEASLES VIRUS ENCODING A TUMOR ANTIGEN | NOBLE, MARCIA STEPHENS | 44d overdue |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | LEE, CHIHYI NMN | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 44d overdue |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | ANDERSON, JAMES D | 44d overdue |
| 19568483 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ABDALHAMEED, MANAHIL MIRGHANI ALI | — |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | — |
| 19407334 | REINFORCED SLIDING MITT INCLUDING PROTECTION GUARD WITH TREAD FOR BASEBALL AND SOFTBALL | MORAN, KATHERINE M | — |
| 19252210 | COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING THE POSITION OF A HOLE OR A CRACK IN A DRILL STRING AND COMPUTER-READABLE STORAGE MATERIAL | QUAIM, LAMIA | — |
| 19047044 | SEMq System for Identification, Determination, Characterization, and/or Quantification of Groundwater or Aquifers | WALKER, CHRISTOPHER RICHARD | — |
| 19018493 | RETAIL INFORMATION DISPLAY SYSTEM | GOODMAN, MATTHEW PARKER | — |
| Art Unit | Apps |
|---|---|
| 1629 | 4 |
| 3791 | 4 |
| 1616 | 3 |
| 1625 | 3 |
| 1622 | 2 |
| 1691 | 2 |
| 1621 | 2 |
| 1619 | 2 |
| 1628 | 2 |
| 1638 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19568483 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Final Rejection | — | Pending | Mar 16, 2026 |
| 19413522 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | TRAN, ERIC | 1629 | §102§112 | Non-Final OA | — | Pending | Dec 09, 2025 |
| 19407334 | REINFORCED SLIDING MITT INCLUDING PROTECTION GUARD WITH TREAD FOR BASEBALL AND SOFTBALL | Dynasty Baseball, LLC | MORAN, KATHERINE M | 3732 | §103§112 | Non-Final OA | — | Pending | Dec 03, 2025 |
| 19252210 | COMPUTER-IMPLEMENTED METHOD FOR IDENTIFYING THE POSITION OF A HOLE OR A CRACK IN A DRILL STRING AND COMPUTER-READABLE STORAGE MATERIAL | Engineering Simulation And Scientific Software Ltda. | QUAIM, LAMIA | 3676 | §101§112 | Non-Final OA | — | Pending | Jun 27, 2025 |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | TRAN, ERIC | 1629 | §102§103§112 | Non-Final OA | 44d overdue | Pending | Apr 25, 2025 |
| 19047044 | SEMq System for Identification, Determination, Characterization, and/or Quantification of Groundwater or Aquifers | G-Strata Spa | WALKER, CHRISTOPHER RICHARD | §103 | Non-Final OA | — | Pending | Feb 06, 2025 | |
| 19018493 | RETAIL INFORMATION DISPLAY SYSTEM | Sagenet LLC | GOODMAN, MATTHEW PARKER | 3637 | §103§112 | Non-Final OA | — | Pending | Jan 13, 2025 |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | Caamtech, Inc. | ANDERSON, JAMES D | 1629 | §102§112 | Non-Final OA | 44d overdue | Pending | Oct 18, 2024 |
| 18903459 | MECHANICAL VAPOR RE-COMPRESSOR HEAT PUMP FOR SEPARATING CO2 FROM WATER VAPOR IN TEMPERATURE-VACUUM SWING ADSORPTION CYCLES | Carbon Capture Inc. | JONES, CHRISTOPHER P | §112 | Non-Final OA | — | Pending | Oct 01, 2024 | |
| 18898755 | CRYSTALLINE 5-METHOXY-DIPROPYL TRYPTAMINE COMPOUNDS | Caamtech, Inc. | OH, TAYLOR V | §103§112DP | Non-Final OA | — | Pending | Sep 27, 2024 | |
| 18897504 | MECHANICAL VAPOR RE-COMPRESSOR HEAT PUMP FOR SEPARATING CO2 FROM WATER VAPOR IN TEMPERATURE-VACUUM SWING ADSORPTION CYCLES | Carbon Capture Inc. | JONES, CHRISTOPHER P | §112 | Non-Final OA | — | Pending | Sep 26, 2024 | |
| 18844280 | INHIBITORS OF FLI1 AND ERG | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | CHAO, ALLEN | §112 | Non-Final OA | — | Pending | Sep 05, 2024 | |
| 18815064 | IONIZABLE LIPID NANOPARTICLES FOR IN UTERO mRNA DELIVERY | William Peranteau | PACKARD, BENJAMIN J | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18781180 | CRYSTALLINE BIS-MIPROCIN FUMARATE | Caamtech, Inc. | JACKSON, SHAWQUIA | §112DP | Non-Final OA | — | Pending | Jul 23, 2024 | |
| 18665039 | PEPTIDE SLOW-RELEASE FORMULATIONS | Camurus AB | CRAIGO, WILLIAM A | 1615 | §112Other | Non-Final OA | 9d overdue | Pending | May 15, 2024 |
| 18551119 | RISK DETERMINATION FOR A PROTHROMBOTIC THROMBOCYTOPAENIA | Universitaetsmedizin Greifswald | MUI, CHRISTINE T | §101§102§112 | Non-Final OA | — | Pending | Apr 22, 2024 | |
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | Tecsoil Automacao E Sistemas S.A | AWORUNSE, OLUWABUSAYO ADEBANJO | 3662 | §103§112 | Final Rejection | 146d overdue | Pending | Mar 28, 2024 |
| 18695584 | STABILISING THE HUMAN SPINDLE BY KIFC1/HSET | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | BRETZ, COREY LANE | §101§103§112Other | Non-Final OA | — | Pending | Mar 26, 2024 | |
| 18611908 | DOSAGE FORMS AND THERAPEUTIC USES OF L-4-CHLOROKYNURENINE | Vistagen Therapeutics, Inc. | HUI, SAN MING R | §101§103 | Non-Final OA | — | Pending | Mar 21, 2024 | |
| 18691986 | ASA-COPOLYMER COMPOSITIONS WITH INCREASED TRANSMITTANCE AND PROCESS FOR THE PREPARATION THEREOF | Ineos Styrolution Group GmbH | SALAMON, PETER A | §103 | Non-Final OA | — | Pending | Mar 14, 2024 | |
| 18688672 | METHOD FOR PRODUCING PRESERVED COLLAGENOUS CONNECTIVE TISSUE, COLLAGENOUS CONNECTIVE TISSUE, USES THEREOF AND KIT FOR IMPLANT IN TISSUES | Labcor Laboratorios Ltda | PENNINGTON, KATIE LEIGH | 1634 | §103§112DP | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18683846 | N-SUBSTITUTED INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | BELL, SARA ELIZABETH | 1625 | §102§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683842 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | WEDDINGTON, KEVIN E | 1629 | §112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18683854 | 3-CYCLOAMINO-INDOLE COMPOUNDS AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | MAHLUM, JONATHAN DAVIS | 1625 | §102§103§112Other | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18407432 | WIRELESS HEART TELEMETRY ELECTRODES AND PATIENT MONITORING SYSTEM | Jmad Creations, LLC | WINAKUR, ERIC FRANK | 3791 | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 |
| 18573732 | CROSS-LINKING POLYSACCHARIDE WITH FIBROIN AND USES OF THE OBTAINED MATERIAL | Merz Pharma GmbH & Co. Kgaa | ALDARONDO, DASIA ALI | §102§103 | Non-Final OA | — | Pending | Dec 22, 2023 | |
| 18572257 | PROTEIN BIOMARKER INDICATORS OF NEUROLOGICAL INJURY AND/OR DISEASE AND METHODS OF USE THEREOF | Brainbox Solutions, Inc. | VOLKOV, ALEXANDER ALEXANDROVIC | §101§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 | |
| 18569507 | HIGH CLARITY AND DUCTILE MOLDING COMPOSITION COMPRISING A SMMA COPOLYMER AND A SBC-BLOCK COPOLYMER | Ineos Styrolution Group GmbH | FOSS, DAVID ROGER | DP | Non-Final OA | — | Pending | Dec 12, 2023 | |
| 18563898 | HALLUCINOGEN-FATTY ACID COMBINATION | Mindset Pharma Inc. | RONEY, CELESTE A | 1612 | §112 | Non-Final OA | — | Pending | Nov 23, 2023 |
| 18562183 | MICROORGANISM STRAIN AND METHOD FOR ANTIBIOTIC-FREE PLASMID-BASED FERMENTATION | Gen-H Genrtic Engineering Heidelberg GmbH | DICKENS, AMELIA NICOLE | 1645 | §102§103§112 | Final Rejection | — | Pending | Nov 17, 2023 |
| 18559245 | MICROBIAL INOCULANTS FOR PLANT GROWTH AND PATHOGEN RESISTANCE | Full Circle Microbes, Inc. | LIU, SUE XU | 1616 | §101§102§103Other | Non-Final OA | — | Pending | Nov 06, 2023 |
| 18553868 | PSEUDO SOLID PHASE PROTECTING GROUP AND METHODS FOR THE SYNTHESIS OF OLIGONUCLEOTIDES AND OLIGONUCLEOTIDE CONJUGATES | BACHEM AG | CREWS, JARET JAMES | 1691 | §103 | Final Rejection | — | Pending | Oct 04, 2023 |
| 18478427 | PRODUCTS AND METHODS FOR MONITORING ADHERENCE TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR THERAPY | Orasure Technologies, Inc. | OGUNTADE, ELIZABETH BISOLA | 1677 | §103§112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18279293 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | SHTERENGARTS, SAMANTHA L | 1623 | §112 | Final Rejection | 48d | Pending | Aug 29, 2023 |
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | 5d | Pending | Aug 29, 2023 |
| 18360612 | PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS | Previpharma Consulting GmbH | XU, QING | 1656 | §103§112Other | Final Rejection | 9d | Pending | Jul 27, 2023 |
| 18262945 | CALCIUM HYDROXYAPATITE PARTICLES AND USE THEREOF | Merz North America, Inc. | MITCHELL, EDWIN COLEMAN | 1619 | §103 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | Caamtech, Inc. | SPAINE, ROBERT FRANKLIN | 1655 | §101§103Other | Non-Final OA | 441d overdue | Pending | Jul 14, 2023 |
| 18260711 | PROTECTED ALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, Inc. | CHICKS, ASHLI ARIANA | 1626 | §102Other | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18348866 | CURABLE COATING COMPOSITIONS HAVING SUPERHYDROPHOBIC, ANTI-ICING, AND ANTI-CORROSION PROPERTIES | Ndsu Research Foundation | MILLER, BETHANY MACKENZIE | 1787 | §103§112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 18259683 | PLANT MATERIAL RECYCLING INOCULANT AND USES THEREOF | Imio Technologies, Inc. | STEINKE, SEAN JAMES | 1619 | §101§102§103§112Other | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | LEE, CHIHYI NMN | 1628 | §103§112 | Final Rejection | 26d overdue | Pending | Jun 05, 2023 |
| 18310945 | PREVENTING DECOMPOSITION IN SODIUM CYANIDE COMPOSITIONS | Cyanco Corporation | NGUYEN, CAM N | 1736 | §102§112 | Non-Final OA | — | Pending | May 02, 2023 |
| 18299857 | STATIC MAGNETIC FIELD GENERATOR FOR TREATMENT OF CANCER | BRAIN & BEYONDS CO., LTD. | LANDEEN, BROGAN RANE | 3791 | §101§103 | Final Rejection | 2d overdue | Pending | Apr 13, 2023 |
| 18245053 | USE OF ACTIVE SUBSTANCES WITH ANTIVIRAL, ANTI MALARIAL, AND/OR MUCOLYTIC PROPERTIES IN THE TREATMENT OF VIRAL LUNG DISEASES INCLUDING COVID-19 BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Istanbul Universitesi Rektolugu | HAGHIGHATIAN, MINA | 1616 | §102§103§112 | Final Rejection | — | Pending | Mar 13, 2023 |
| 18178041 | COMPOSITION FOR IMPROVING THE APPEARANCE OF AGEING SKIN | Merz Pharma GmbH & Co. Kgaa | PURDY, KYLE A | 1611 | §103 | Non-Final OA | — | Pending | Mar 03, 2023 |
| 18105460 | CONJUGATES COMPRISING REVERSIBLE LINKERS AND USES THEREOF | Ascendis Pharma A/S | JOHNSON, CHRISTOPHER LINDSAY | 1691 | — | Final Rejection | 34d | Pending | Feb 03, 2023 |
| 18161828 | MIXTURES AND FORMULATIONS | Camurus AB | CONIGLIO, AUDREA JUNE BUCKLEY | 1617 | §103DP | Non-Final OA | — | Pending | Jan 30, 2023 |
| 18051678 | BIO-BASED FURANIC DI(METH)ACRYLATES AS REACTIVE DILUENTS FOR UV CURABLE COATINGS | Ndsu Research Foundation | EGWIM, KELECHI CHIDI | 1762 | §102 | Final Rejection | 4d overdue | Pending | Nov 01, 2022 |
| 17997600 | THERMOPLASTIC POLYMER COMPOSITION WITH REDUCED MIGRATION OF STABILISERS | Ineos Styrolution Group GmbH | RODD, CHRISTOPHER M | 1766 | §103 | Non-Final OA | — | Pending | Oct 31, 2022 |
| 17916199 | NANOPARTICLE PROVISION MEDIUM FOR THERMOTHERAPY AND THERMOTHERAPY SYSTEM USING SAME | BRAIN & BEYONDS CO., LTD. | COX, THADDEUS B | 3791 | §102§103§112 | Final Rejection | 23d | Pending | Sep 30, 2022 |
| 17904404 | DRG-MDM2-5 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR | Istanbul Teknik Universitesi | MCANANY, JOHN D | 1625 | §112 | Final Rejection | — | Pending | Aug 17, 2022 |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | BAHCESEHIR UNIVERSITESI | MYERS, CARLA J | 1682 | §102§112 | Final Rejection | 187d overdue | Pending | Aug 02, 2022 |
| 17747557 | MEASLES VIRUS ENCODING A TUMOR ANTIGEN | Ruprecht-Karls-Universitat Heidelberg | NOBLE, MARCIA STEPHENS | 1632 | §103§112 | Non-Final OA | 44d overdue | Pending | May 18, 2022 |
| 17776092 | APPARATUS AND METHOD FOR ITERATIVE POLYMER SYNTHESIS | BACHEM AG | BUNKER, AMY M | 1684 | §103 | Non-Final OA | — | Pending | May 11, 2022 |
| 17773241 | B-CELL ANTIBODY RECEPTOR AND USE THEREOF | Medinet Co., Ltd. | SPENCER, ANDREA LYNNE MORRIS | 1631 | §103 | Final Rejection | — | Pending | Apr 29, 2022 |
| 17767299 | THERMOPLASTIC RECYCLING MOLDING COMPOSITION BASED ON RECYCLED ACRYLONITRILE-BUTADIENE-STYRENE COPOLYMERS AND PROCESS FOR ITS PREPARATION | Ineos Styrolution Group GmbH | ILLING, CAITLIN NORINE | 1767 | §103 | Non-Final OA | — | Pending | Apr 07, 2022 |
| 17627988 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | Caamtech, Inc. | NOTTINGHAM, KYLE GREGORY | 1621 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 18, 2022 |
| 17596832 | CONJUGATES OF AN ELECTRON-DONATING NITROGEN OR TERTIARY AMINE COMPRISING COMPOUNDS | Ascendis Pharma A/S | ELENISTE, PIERRE PAUL | 1622 | §103§112 | Final Rejection | 1d overdue | Pending | Dec 20, 2021 |
| 17596831 | CONJUGATES OF pi-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS | Ascendis Pharma A/S | MOSHER, ERIC PARKER | 1600 | §102§103 | Final Rejection | — | Pending | Dec 20, 2021 |
| 17612326 | BODY TEMPERATURE DIAGNOSTICS | Vivosensmedical GmbH | TU, AURELIE H | 3791 | §101§102§103§112 | Final Rejection | 29d | Pending | Nov 18, 2021 |
| 17495069 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, Inc. | CORNET, JEAN P | 1628 | §103§112Other | Non-Final OA | 54d | Pending | Oct 06, 2021 |
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | MCDOWELL, BRIAN E | 1624 | §102 | Final Rejection | 89d overdue | Pending | Jul 28, 2021 |
| 17422962 | PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS | Previpharma Consulting GmbH | MOSS, NATALIE M | 1653 | §101§103§112 | Non-Final OA | 33d | Pending | Jul 14, 2021 |
| 17312249 | A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE | Henry Johannes Greten | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112 | Non-Final OA | — | Pending | Jun 09, 2021 |
| 17186762 | SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF TOPICAL SUBSTANCES | Cryoconcepts LP | SMITH, PETER DANIEL | 3781 | §103 | Final Rejection | 46d overdue | Pending | Feb 26, 2021 |
| 16968146 | IMPROVED ALPHA-BETA T PROCESSED CELL PRODUCTION METHOD | Medinet Co., Ltd. | VIVLEMORE, TRACY ANN | 1638 | §103 | Non-Final OA | — | Pending | Aug 06, 2020 |
| 16456773 | RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY | Ruprecht-Karls Universitaet | VIVLEMORE, TRACY ANN | 1638 | §103§112 | Non-Final OA | 98d overdue | Pending | Jun 28, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial